juvenile diabetes [2008-03-06 19:47:08]


Generex Biotechnology to Make Presentations At International

FOXBusiness - USA
"Oral Insulin at Lunchtime in Juvenile Type-1 DM Subjects
Maintained on a Basal Glargine Insulin and Pre-Breakfast and Pre-Dinner
Regular Insulin," by
See all stories on this topic





.

Leave a Reply